Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Mullingar

7 clinical trials in Mullingar, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Mullingar at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Mullingar

Open in trial search
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Coeliac disease

Not recruiting
Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Kan-101
  • Sponsor:Kanyos Bio Inc.

Colitis ulcerative

Not recruiting
Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Mullingar

What the registry says about research in the country

01 Gastrointestinal Disorders

Innovative research focusing on celiac disease treatment, evaluating a novel therapeutic agent KAN-101 for its effectiveness in protecting against gluten-induced intestinal changes.

  • Celiac Disease Management
  • Intestinal Mucosa Protection
  • Gluten Challenge Response

The trials aim to measure changes in intestinal tissue structure and assess therapeutic tolerance.

02 Inflammatory Bowel Disease

Comprehensive studies on ulcerative colitis examining the novel compound obefazimod, with both short-term and long-term evaluation protocols for efficacy and safety.

  • Endoscopic Improvement
  • Symptomatic Remission
  • Long-term Safety Assessment

Research focuses on moderate to severe cases with extended follow-up periods.

03 Advanced Digestive Disease Research

Groundbreaking research into Crohn's Disease treatment, investigating targeted therapies for adult patients with moderate to severe symptoms.

  • Therapeutic Efficacy
  • Safety Profiling
  • Mechanistic Assessment

The studies aim to advance personalized treatment approaches for inflammatory bowel conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.